WEKO3
アイテム
{"_buckets": {"deposit": "be765f0c-3ede-4902-a16b-dd02f30dc4bd"}, "_deposit": {"created_by": 2, "id": "16671", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "16671"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00016671", "sets": ["30"]}, "author_link": ["64019", "64018", "64021", "64012", "64010", "64015", "64016", "64011", "64017", "64020", "64013", "64009", "64014"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2006-04", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "316", "bibliographicPageStart": "313", "bibliographicVolumeNumber": "45", "bibliographic_titles": [{"bibliographic_title": "Internal Medicine"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab, who did not respond well to conventional therapy with glucocosteroid and methotrexate. Takayasu arteritis had developed in a 24yearold woman (March 2003) who had been treated with glucocorticoid including methylprednisolone pulse therapy and methotrexate; however, she relapsed during the tapering of the dosage of oral prednisolone. Nineteen months after the first administration of glucocorticoid, 3 mg/kg of infliximab was introduced to the patient. The therapeutic efficacy of infliximab was markedly demonstrated; the patient\u0027s Creactive protein (CRP) value returned to almost normal range with subsequent tapering of the dosage of oral prednisolone in the absence of further relapse. This is the first case presentation of TA in Japan successfully treated with infliximab.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Internal Medicine, vol.45(5), pp.313-316; 2006", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本内科学会"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.2169/internalmedicine.45.1377", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "Copyright (c) 2006 (社)日本内科学会"}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "09182918", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_62": {"attribute_name": "出版者別言語", "attribute_value_mlt": [{"subitem_text_value": "The Japanese Society of Internal Medicine"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Tanaka, Fumiko"}], "nameIdentifiers": [{"nameIdentifier": "64009", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawakami, Atsushi"}], "nameIdentifiers": [{"nameIdentifier": "64010", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iwanaga, Nozomi"}], "nameIdentifiers": [{"nameIdentifier": "64011", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tamai, Mami"}], "nameIdentifiers": [{"nameIdentifier": "64012", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Izumi, Yasumori"}], "nameIdentifiers": [{"nameIdentifier": "64013", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aratake, Kouichiro"}], "nameIdentifiers": [{"nameIdentifier": "64014", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Arima, Kazuhiko"}], "nameIdentifiers": [{"nameIdentifier": "64015", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamachi, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "64016", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakamura, Hideki"}], "nameIdentifiers": [{"nameIdentifier": "64017", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Huang, Mingguo"}], "nameIdentifiers": [{"nameIdentifier": "64018", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ida, Hiroaki"}], "nameIdentifiers": [{"nameIdentifier": "64019", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Origuchi, Tomoki"}], "nameIdentifiers": [{"nameIdentifier": "64020", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Eguchi, Katsumi"}], "nameIdentifiers": [{"nameIdentifier": "64021", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-23"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "IM_45_5_313.pdf", "filesize": [{"value": "197.8 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 197800.0, "url": {"label": "IM_45_5_313.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/16671/files/IM_45_5_313.pdf"}, "version_id": "36c3ba79-eb6d-44f5-828b-1119fe14c220"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Takayasu arteritis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "infliximab", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate"}]}, "item_type_id": "2", "owner": "2", "path": ["30"], "permalink_uri": "http://hdl.handle.net/10069/22554", "pubdate": {"attribute_name": "公開日", "attribute_value": "2009-12-04"}, "publish_date": "2009-12-04", "publish_status": "0", "recid": "16671", "relation": {}, "relation_version_is_last": true, "title": ["Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate"], "weko_shared_id": 2}
Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate
http://hdl.handle.net/10069/22554
http://hdl.handle.net/10069/22554a862001e-c3c4-43ff-8a2d-a8155d30f23e
名前 / ファイル | ライセンス | アクション |
---|---|---|
IM_45_5_313.pdf (197.8 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2009-12-04 | |||||
タイトル | ||||||
タイトル | Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Takayasu arteritis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | infliximab | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Tanaka, Fumiko
× Tanaka, Fumiko× Kawakami, Atsushi× Iwanaga, Nozomi× Tamai, Mami× Izumi, Yasumori× Aratake, Kouichiro× Arima, Kazuhiko× Kamachi, Makoto× Nakamura, Hideki× Huang, Mingguo× Ida, Hiroaki× Origuchi, Tomoki× Eguchi, Katsumi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab, who did not respond well to conventional therapy with glucocosteroid and methotrexate. Takayasu arteritis had developed in a 24yearold woman (March 2003) who had been treated with glucocorticoid including methylprednisolone pulse therapy and methotrexate; however, she relapsed during the tapering of the dosage of oral prednisolone. Nineteen months after the first administration of glucocorticoid, 3 mg/kg of infliximab was introduced to the patient. The therapeutic efficacy of infliximab was markedly demonstrated; the patient's Creactive protein (CRP) value returned to almost normal range with subsequent tapering of the dosage of oral prednisolone in the absence of further relapse. This is the first case presentation of TA in Japan successfully treated with infliximab. | |||||
書誌情報 |
Internal Medicine 巻 45, 号 5, p. 313-316, 発行日 2006-04 |
|||||
出版者 | ||||||
出版者 | 日本内科学会 | |||||
出版者別言語 | ||||||
The Japanese Society of Internal Medicine | ||||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 09182918 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.2169/internalmedicine.45.1377 | |||||
権利 | ||||||
権利情報 | Copyright (c) 2006 (社)日本内科学会 | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Internal Medicine, vol.45(5), pp.313-316; 2006 |